Axa’s Maxim Integrated Products MXIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,397
Closed -$674K 1360
2021
Q2
$674K Buy
6,397
+708
+12% +$69.3K ﹤0.01% 1062
2021
Q1
$520K Sell
5,689
-81,403
-93% -$7.46M ﹤0.01% 1074
2020
Q4
$7.72M Sell
87,092
-6,984
-7% -$551K 0.02% 585
2020
Q3
$6.36M Sell
94,076
-13,461
-13% -$911K 0.02% 564
2020
Q2
$6.52M Buy
107,537
+68,226
+174% +$3.8M 0.03% 540
2020
Q1
$1.91M Sell
39,311
-1,500
-4% -$86K 0.01% 746
2019
Q4
$2.51M Buy
40,811
+18,932
+87% +$1.1M 0.01% 770
2019
Q3
$1.27M Sell
21,879
-105
-0.5% -$6.08K 0.01% 948
2019
Q2
$1.31M Buy
+21,984
New +$1.25M 0.01% 921
2018
Q4
Sell
-8,075
Closed -$455K 1403
2018
Q3
$455K Hold
8,075
﹤0.01% 1161
2018
Q2
$474K Sell
8,075
-189
-2% -$11K ﹤0.01% 1144
2018
Q1
$497K Hold
8,264
﹤0.01% 1163
2017
Q4
$432K Hold
8,264
﹤0.01% 1173
2017
Q3
$395K Buy
8,264
+681
+9% +$31.2K ﹤0.01% 1144
2017
Q2
$341K Buy
7,583
+400
+6% +$18.4K ﹤0.01% 1120
2017
Q1
$323K Buy
7,183
+883
+14% +$38.7K ﹤0.01% 1151
2016
Q4
$243K Hold
6,300
﹤0.01% 1178
2016
Q3
$252K Hold
6,300
﹤0.01% 1132
2016
Q2
$225K Hold
6,300
﹤0.01% 1151
2016
Q1
$232K Buy
+6,300
New +$211K ﹤0.01% 1127
2014
Q4
Sell
-116,300
Closed -$3.52M 1504
2014
Q3
$3.52M Sell
116,300
-8,700
-7% -$274K 0.02% 611
2014
Q2
$4.23M Sell
125,000
-25,000
-17% -$833K 0.02% 593
2014
Q1
$4.97M Hold
150,000
0.02% 523
2013
Q4
$4.19M Hold
150,000
0.02% 567
2013
Q3
$4.47M Sell
150,000
-490,739
-77% -$14M 0.02% 539
2013
Q2
$17.8M Buy
+640,739
New +$19.4M 0.09% 232

Other funds holding MXIM

Axa's MXIM Position: Q3 2021 in Review

Axa sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 6,397 shares — an estimated $674K sold.

Axa first reported a position in MXIM in Q2 2013 and held it in 26 quarters. The position peaked at $17.8M in Q2 2013. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.

  • Axa reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
  • Axa sold 6,397 Maxim Integrated Products shares in Q3 2021, an estimated $674K.
  • Axa first reported a position in Maxim Integrated Products in Q2 2013 and held it in 26 quarters.
  • Axa's Maxim Integrated Products position peaked at $17.8M in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.